[CYCC] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
10-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -11.39%
YoY- -2.19%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 10 16 0 0 0 0 0 -
PBT -2,167 -6,699 -6,110 -5,985 -2,537 -2,174 -2,369 -1.47%
Tax -210 -602 -1,014 -998 -281 -273 -301 -5.81%
NP -2 -6,097 -5,096 -4,987 -2,256 -1,901 -2,068 -68.51%
Tax Rate - - - - - - - -
Total Cost 12 6,113 5,096 4,987 2,256 1,901 2,068 -57.57%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -19.57 -38,106.25 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.00 -7.23 -0.41 -0.53 -0.46 -2.21 -3.45 -
EPS Diluted -0.00 -7.23 -0.41 -0.53 -0.46 -2.21 -3.45 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.